Basilea Pharmaceutica 2020 UBS Healthcare Conference Presentation

Basilea Pharmaceutica is a commercial-stage biotech company focused on oncology and infectious diseases with two marketed hospital anti-infective brands (Cresemba and Zevtera) and three oncology candidates in development. The company emphasizes sustainable growth potential through commercialized brands, an innovative pipeline, and established partnership capabilities across development and commercial stages.